• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs up Expected

FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs up Expected

February 26, 2021
Soros-Backed Philadelphia DA Wins Key Primary Race After Presiding Over Record-High Murders

Soros-Backed Philadelphia DA Wins Key Primary Race After Presiding Over Record-High Murders

May 20, 2025
Delaware Legalizes Assisted Suicide After Protracted Legal Battle

Delaware Legalizes Assisted Suicide After Protracted Legal Battle

May 20, 2025
‘One Step Ahead’: House Republicans Want To Make America’s Borders Even Harder To Illegally Cross

‘One Step Ahead’: House Republicans Want To Make America’s Borders Even Harder To Illegally Cross

May 20, 2025
How GOP Can Wage ‘War On Regulations’ With Trump’s ‘One, Big, Beautiful Bill’

How GOP Can Wage ‘War On Regulations’ With Trump’s ‘One, Big, Beautiful Bill’

May 20, 2025
GOP Calls Senate Dems’ Bluff On ‘Newfound’ Filibuster Concern Now That EV Mandates Are On Chopping Block

GOP Calls Senate Dems’ Bluff On ‘Newfound’ Filibuster Concern Now That EV Mandates Are On Chopping Block

May 20, 2025
Senate Dems Join GOP To Approve Major Trump Campaign Promise In Surprise Move

Senate Dems Join GOP To Approve Major Trump Campaign Promise In Surprise Move

May 20, 2025
GOP Pushes Tax To Pay For Trump Agenda And Depress Illegal Immigration In One Fell Swoop

GOP Pushes Tax To Pay For Trump Agenda And Depress Illegal Immigration In One Fell Swoop

May 20, 2025
Jury In Sean ‘Diddy’ Combs’ Sex Trial Won’t Be Confirmed Until Friday

Legal Analyst Says ‘Acquittal is Very Likely’ in Sean ‘Diddy’ Combs Sex Trial

May 20, 2025
‘Civil War Of Epic Proportions’: Syria Could Be ‘Weeks’ Away From Implosion Despite Sanctions Relief, Rubio Warns

‘Civil War Of Epic Proportions’: Syria Could Be ‘Weeks’ Away From Implosion Despite Sanctions Relief, Rubio Warns

May 20, 2025
Nancy Mace Shows Nude Photo Of Herself During Hearing

Nancy Mace Shows Nude Photo Of Herself During Hearing

May 20, 2025
Trump Vaccine Policy Limits Access to COVID Shots

Trump Vaccine Policy Limits Access to COVID Shots

May 20, 2025
GOP Rep Who Was Censured For Opposing Trans Athletes Sticks It To Democrats With Supreme Court Victory

GOP Rep Who Was Censured For Opposing Trans Athletes Sticks It To Democrats With Supreme Court Victory

May 20, 2025
  • Donald Trump
  • State of the Union
  • Elon Musk
  • Tariffs
  • Congress
  • Faith
  • Immigration
Tuesday, May 20, 2025
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs up Expected

by Reuters
February 26, 2021 at 7:33 am
in News
240 12
0
FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs up Expected

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

A panel of expert advisers to the U.S. Food and Drug Administration is expected to recommend authorization of a one-dose COVID-19 vaccine from Johnson & Johnson on Friday, setting the stage for the unleashing of millions more doses across the country next week.

After it receives the recommendation, the FDA is likely to authorize the vaccine for emergency use within a day or so, making it the third available in the United States, and the only one that requires just one shot.

The panel, consisting of doctors, infectious disease experts and medical researchers, will convene at 9:00am ET (1400 GMT) and vote in favor or against the vaccine’s use several hours later at the end of the meeting.

The panel will consider whether the benefits of the vaccine outweigh its risk for use in people aged 18 and older.

Officials from the FDA, U.S Centers for Disease Control and Prevention and J&J discuss the vaccine’s trial data.

In a 44,000-person trial, the vaccine overall was 66% effective at preventing moderate-to-severe cases of COVID-19 compared with a placebo.

The effectiveness of the one-dose vaccine varied over time and location. In the United States, the effectiveness was 74% at 14 days and 72% two weeks later, while the shot was 64% effective at stopping moderate-to-severe COVID-19 after 28 days in South Africa, where a worrying new variant has swept across the country.

The vaccine was 100% effective at preventing hospitalizations 28 days after vaccination and there were no COVID-19 deaths among those who received the shot.

“In the context of the pandemic, the FDA is likely to issue an emergency use authorization (EUA) based on the data,” said UBS analyst Navin Jacob ahead of the panel meeting.

The J&J vaccine can be stored in normal refrigerator temperatures, making distribution easier than that of the Pfizer Inc/BioNTech SE and Moderna Inc vaccines that use mRNA technology and must be shipped and stored frozen.

J&J’s vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.

Three to four million doses of the vaccine are expected to be rolled out next week.

(Reporting by Manas Mishra in Bengaluru and Michael Erman in New York; Editing by Caroline Humer and Bill Berkrot)

Tags: Coronavirus Outbreak
Share196Tweet123
Reuters

Reuters

Reuters is an international news organization.

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th